SCHEMBL308747

SCHEMBL308747

c1ccc(-c2ccc(N(c3ccccc3)c3ccccc3)cc2-c2cccc(N(c3ccccc3)c3ccccc3)c2)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 3/20 0.42
ALDH1A1 P00352 3/20 0.42
MAPT P10636 3/20 0.42
KDM4E B2RXH2 2/20 0.42
TDP1 Q9NUW8 2/20 0.42
CYP1A2 P05177 1/20 0.42
CYP3A4 P08684 1/20 0.42
CYP2D6 P10635 1/20 0.42
CYP2C9 P11712 1/20 0.42
CYP2C19 P33261 1/20 0.42
MEN1 O00255 3/20 0.36
KMT2A Q03164 3/20 0.36
CRHBP P24387 1/20 0.36
ATM Q13315 1/20 0.36
CRHR2 Q13324 1/20 0.36
TLR9 Q9NR96 1/20 0.36
BACE1 P56817 1/20 0.35
ALOX5 P09917 1/20 0.35
APP P05067 1/20 0.35
ESR2 Q92731 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19998700 0.98 ALDH1A1 (0.41) L3MBTL1ALDH1A1MAPTKDM4ETDP1
SCHEMBL360295 0.96 ALDH1A1 (0.39) L3MBTL1ALDH1A1MAPTKDM4ETDP1
SCHEMBL17360005 0.96 L3MBTL1 (0.39) L3MBTL1ALDH1A1MAPTKDM4ETDP1
SCHEMBL17359999 0.96 L3MBTL1 (0.39) L3MBTL1ALDH1A1MAPTKDM4ETDP1
SCHEMBL17360013 0.95 L3MBTL1 (0.38) L3MBTL1ALDH1A1MAPTKDM4ETDP1
SCHEMBL19579535 0.94 ALDH1A1 (0.46) L3MBTL1ALDH1A1MAPTKDM4ETDP1
SCHEMBL17917952 0.94 ALDH1A1 (0.46) L3MBTL1ALDH1A1MAPTKDM4ETDP1
SCHEMBL24079290 0.93 L3MBTL1 (0.39) L3MBTL1ALDH1A1MAPTKDM4ETDP1
SCHEMBL20620395 0.93 L3MBTL1 (0.39) L3MBTL1ALDH1A1MAPTKDM4ETDP1
SCHEMBL20620389 0.93 L3MBTL1 (0.39) L3MBTL1ALDH1A1MAPTKDM4ETDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 50 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10281831-B2 Imaging members comprising capped structured organic film compositions XEROX CORPORATION (US) 2019-05-07 US disclosed
US-9921500-B2 Fluorinated structured organic film photoreceptor layers XEROX CORPORATION (US) 2018-03-20 US disclosed
US-20170075238-A1 FLUORINATED STRUCTURED ORGANIC FILM PHOTORECEPTOR LAYERS XEROX CORPORATION (US) 2017-03-16 US disclosed
US-9567425-B2 Periodic structured organic films XEROX CORPORATION (US) 2017-02-14 US disclosed
US-20170022338-A1 PERIODIC STRUCTURED ORGANIC FILMS XEROX CORPORATION 2017-01-26 US disclosed
EP-2403657-B1 PROCESS FOR PREPARING STRUCTURED ORGANIC FILMS (SOFS) VIA A PRE-SOF XEROX CORP (US) 2016-12-28 EP disclosed
EP-2408572-B1 COMPOSITE STRUCTURED ORGANIC FILMS XEROX CORP (US) 2016-12-21 EP disclosed
US-9523928-B2 Fluorinated structured organic film photoreceptor layers U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, AS COLLATERAL AGENT 2016-12-20 US disclosed
EP-2403656-B1 ELECTRONIC DEVICES COMPRISING A STRUCTURED ORGANIC FILM XEROX CORP (US) 2016-12-07 EP disclosed
EP-2403858-B1 STRUCTURED ORGANIC FILMS HAVING AN ADDED FUNCTIONALITY XEROX CORP (US) 2016-12-07 EP disclosed
US-20100227157-A1 COMPOSITE STRUCTURED ORGANIC FILMS XEROX CORPORATION (US) 2010-09-09 US disclosed
US-20100228025-A1 STRUCTURED ORGANIC FILMS HAVING AN ADDED FUNCTIONALITY XEROX CORPORATION (US) 2010-09-09 US disclosed
US-20100227998-A1 STRUCTURED ORGANIC FILMS XEROX CORPORATION (US) 2010-09-09 US disclosed
US-20100227081-A1 MIXED SOLVENT PROCESS FOR PREPARING STRUCTURED ORGANIC FILMS XEROX CORPORATION (US) 2010-09-09 US disclosed
US-20100224867-A1 ELECTRONIC DEVICES COMPRISING STRUCTURED ORGANIC FILMS XEROX CORPORATION (US) 2010-09-09 US disclosed
US-20100227071-A1 PROCESS FOR PREPARING STRUCTURED ORGANIC FILMS (SOFS) VIA A PRE-SOF XEROX CORPORATION (US) 2010-09-09 US disclosed
EP-0805143-B1 ORGANIC ELECTROLUMINESCENT ELEMENT, ORGANIC THIN FILM, AND TRIAMINE COMPOUNDS IDEMITSU KOSAN CO (JP) 2001-12-05 EP disclosed
US-6074734-A Organic electroluminescence device, organic thin film, and triamine compound IDEMITSU KOSAN CO., LTD. (JP) 2000-06-13 US disclosed
EP-0805143-A1 ORGANIC ELECTROLUMINESCENT ELEMENT, ORGANIC THIN FILM, AND TRIAMINE COMPOUNDS IDEMITSU KOSAN COMPANY LIMITED (JP) 1997-11-05 EP disclosed
US-5466392-A Organic electroluminescence device and compound having an aluminum complex structure IDEMITSU KOSAN CO., LTD. (JP) 1995-11-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100224867-A1 ELECTRONIC DEVICES COMPRISING STRUCTURED ORGANIC FILMS EPCAM, EPHA6, EED L3MBTL1 342/4885ALDH1A1 866/4885MAPT 787/4885
US-20100228025-A1 STRUCTURED ORGANIC FILMS HAVING AN ADDED FUNCTIONALITY VIM, PUF60, EPCAM L3MBTL1 460/4885ALDH1A1 1258/4885MAPT 376/4885
US-20100227998-A1 STRUCTURED ORGANIC FILMS VIM, PUF60, EPCAM L3MBTL1 310/4885ALDH1A1 1213/4885MAPT 270/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.